CRITICAL · 9.4

CVE-2018-14786

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulne...

Vulnerability Description

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

CVSS Score

9.4

CRITICAL

CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
LOW
Integrity
HIGH
Availability
HIGH

Affected Products

VendorProductVersions
BdAlaris Gs Firmware<= 2.3.6
BdAlaris Gs-
BdAlaris Gh Firmware<= 2.3.6
BdAlaris Gh-
BdAlaris Cc Firmware<= 2.3.6
BdAlaris Cc-
BdAlaris Tiva Firmware<= 2.3.6
BdAlaris Tiva-

Related Weaknesses (CWE)

References

FAQ

What is CVE-2018-14786?

CVE-2018-14786 is a vulnerability with a CVSS score of 9.4 (CRITICAL). Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulne...

How severe is CVE-2018-14786?

CVE-2018-14786 has been rated CRITICAL with a CVSS base score of 9.4/10. This is considered a critical vulnerability requiring immediate attention.

Is there a patch for CVE-2018-14786?

Check the references section above for vendor advisories and patch information. Affected products include: Bd Alaris Gs Firmware, Bd Alaris Gs, Bd Alaris Gh Firmware, Bd Alaris Gh, Bd Alaris Cc Firmware.